The Myelodysplastic Syndromes
Myelodysplastic syndromes (MDS) are the most common hematological malignancies involving mostly the elderly population. The major morbidity relates to patients’ symptomatic cytopenias.MDS was previously named as “preleukemia “ or “ smoldering leukemia” as the lack of terminal cells in MDS and becau...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Dordrecht :
Springer Netherlands : Imprint: Springer,
2011.
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- 1. PREFACE
- 2. The history of the Myelodysplastic Syndromes
- 3. Susceptibility to MDS: DNA repair and detoxification genes
- 4. Myelodysplastic syndromes/neoplasms: Morphological and Immunohistochemical features and standard evaluation
- 5. Diagnostic Criteria and Classification of Myelodysplastic Syndromes
- 6. Cytogenetics of MDS
- 7. Molecular changes in myelodysplastic syndrome
- 8. Prognostic Scoring in MDS
- 9. Flow Cytometry in Myelodysplastic Syndromes
- 10. MDS as an Autoimmune Process
- 11. The Myelodysplastic Overlap Syndromes
- 12. Iron and copper Metabolismin the Myelodysplastic Syndromes
- 13. Pathogenesis and Management of Iron Overload in MDS
- 14. Cytokines in MDS. Abnormalities and treatment
- 15. Therapeutic Modalities and new molecular targets in MDS
- 16. Haematopoietic Stem Cell Transplantation in MDS for Adults
- 17. JMML and Myelodysplastic Syndrome in children.